Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

cGMP-dependent protein kinase

From Wikipedia, the free encyclopedia
Protein kinase
protein kinase, cGMP-dependent, type I
Crystallographic structure of theleucine zipper domain of human cGMP dependent protein kinase I beta.[1]
Identifiers
SymbolPRKG1
Alt. symbolsPRKGR1B, PRKG1B
NCBI gene5592
HGNC9414
OMIM176894
RefSeqNM_006258
UniProtQ13976
Other data
LocusChr. 10q11.2
Search for
StructuresSwiss-model
DomainsInterPro
protein kinase, cGMP-dependent, type II
Identifiers
SymbolPRKG2
NCBI gene5593
HGNC9416
OMIM601591
RefSeqNM_006259
UniProtQ13237
Other data
LocusChr. 4q13.1-21.1
Search for
StructuresSwiss-model
DomainsInterPro

cGMP-dependent protein kinase orprotein kinase G (PKG) is aserine/threonine-specific protein kinase that is activated bycGMP. Itphosphorylates a number of biologically important targets and is implicated in the regulation ofsmooth muscle relaxation,platelet function,sperm metabolism,cell division, andnucleic acid synthesis.

Genes and proteins

[edit]

PKG are serine/threonine kinases that are present in a variety ofeukaryotes ranging from the unicellular organismParamecium to humans. Two PKGgenes, coding for PKG type I (PKG-I) and type II (PKG-II), have been identified inmammals. TheN-terminus of PKG-I is encoded by two alternatively splicedexons that specify for the PKG-Iα and PKG-Iβisoforms. PKG-Iβ is activated at ~10-fold higher cGMP concentrations than PKG-Iα. The PKG-I and PKG-II arehomodimers of two identicalsubunits (~75 kDa and ~85 kDa, respectively) and share common structural features.

Each subunit is composed of threefunctional domains:

  • (1) anN-terminal domain that mediates homodimerization, suppression of the kinase activity in the absence of cGMP, and interactions with other proteins including protein substrates
  • (2) aregulatory domain that contains two non-identical cGMP-binding sites
  • (3) akinase domain that catalyzes thephosphate transfer fromATP to thehydroxyl group of a serine/threonineside chain of the target protein

Binding of cGMP to the regulatory domain induces a conformational change which stops the inhibition of the catalytic core by the N-terminus and allows thephosphorylation of substrate proteins. Whereas PKG-I is predominantly localized in thecytoplasm, PKG-II is anchored to theplasma membrane by N-terminalmyristoylation.

Tissue distribution

[edit]

In general, PKG-I and PKG-II are expressed in different cell types.

Specifically, in smooth muscle tissue, PKG promotes the opening ofcalcium-activated potassium channels, leading tocell hyperpolarization and relaxation, and blocksagonist activity ofphospholipase C, reducing liberation of stored calcium ions byinositol triphosphate.

Role in cancer

[edit]

Cancerous colon cells stop producing PKG, which apparently limitsbeta-catenin, thus allowing the VEGF enzyme to solicitangiogenesis.[2]

Behavioral genetics inDrosophila melanogaster

[edit]

InDrosophila melanogaster the foraging (for)gene is apolymorphic trait that underlies differences in food-seeking behaviors. Theforlocus is made up of Rover (forR) and Sitter (forS)alleles, with the Rover allele being dominant. Rover individuals typically travel greater distances when foraging for food, while Sitter individuals travel less distance to forage for food. Both Rover and Sitter phenotypes are consideredwild-type, as fruit fly populations typically exhibit a 70:30 Rover-to-Sitter ratio.[3] The Rover and Sitter alleles are located within the 24A3-5 region of theDrosophila melanogaster polytenechromosome, a region which contains the PKG d2g gene. PKG expression levels account for differences inforR andforS allele frequency and therefore behavior as Rover individuals show higher PKG expression than Sitter individuals, and the Sitter phenotype can be converted to Rover by over-expression of the dg2 gene.[4]

See also

[edit]

References

[edit]
  1. ^PDB:3NMD​;Casteel DE, Smith-Nguyen EV, Sankaran B, Roh SH, Pilz RB, Kim C (October 2010)."A crystal structure of the cyclic GMP-dependent protein kinase I{beta} dimerization/docking domain reveals molecular details of isoform-specific anchoring".The Journal of Biological Chemistry.285 (43):32684–8.doi:10.1074/jbc.C110.161430.PMC 2963381.PMID 20826808.
  2. ^Kwon IK, Schoenlein PV, Delk J, Liu K, Thangaraju M, Dulin NO, et al. (April 2008)."Expression of cyclic guanosine monophosphate-dependent protein kinase in metastatic colon carcinoma cells blocks tumor angiogenesis".Cancer.112 (7):1462–70.doi:10.1002/cncr.23334.PMID 18260092.S2CID 4763327.
  3. ^Sokolowski MB (November 2001). "Drosophila: genetics meets behaviour".Nature Reviews. Genetics.2 (11):879–90.doi:10.1038/35098592.PMID 11715043.S2CID 13152094.
  4. ^Osborne KA, Robichon A, Burgess E, Butland S, Shaw RA, Coulthard A, et al. (August 1997). "Natural behavior polymorphism due to a cGMP-dependent protein kinase of Drosophila".Science.277 (5327):834–6.doi:10.1126/science.277.5327.834.PMID 9242616.

External links

[edit]
MAP
Calcium
G protein
Heterotrimeric
cAMP:
cGMP:
Monomeric
Cyclin
Lipid
Otherprotein kinase
Serine/threonine:
Tyrosine:
Serine/threonine/tyrosine
Arginine
Otherprotein phosphatase
Serine/threonine:
Tyrosine:
both:
Apoptosis
GTP-binding protein regulators
Other
Non-specific serine/threonine protein kinases (EC 2.7.11.1)
Pyruvate dehydrogenase kinase (EC 2.7.11.2)
Dephospho-(reductase kinase) kinase (EC 2.7.11.3)
3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring) kinase (EC 2.7.11.4)
(isocitrate dehydrogenase (NADP+)) kinase (EC 2.7.11.5)
(tyrosine 3-monooxygenase) kinase (EC 2.7.11.6)
Myosin-heavy-chain kinase (EC 2.7.11.7)
Fas-activated serine/threonine kinase (EC 2.7.11.8)
Goodpasture-antigen-binding protein kinase (EC 2.7.11.9)
  • -
IκB kinase (EC 2.7.11.10)
cAMP-dependent protein kinase (EC 2.7.11.11)
cGMP-dependent protein kinase (EC 2.7.11.12)
Protein kinase C (EC 2.7.11.13)
Rhodopsin kinase (EC 2.7.11.14)
Beta adrenergic receptor kinase (EC 2.7.11.15)
G-protein coupled receptor kinases (EC 2.7.11.16)
Ca2+/calmodulin-dependent (EC 2.7.11.17)
Myosin light-chain kinase (EC 2.7.11.18)
Phosphorylase kinase (EC 2.7.11.19)
Elongation factor 2 kinase (EC 2.7.11.20)
Polo kinase (EC 2.7.11.21)
Serine/threonine-specific protein kinases (EC 2.7.11.21-EC 2.7.11.30)
Polo kinase (EC 2.7.11.21)
Cyclin-dependent kinase (EC 2.7.11.22)
(RNA-polymerase)-subunit kinase (EC 2.7.11.23)
Mitogen-activated protein kinase (EC 2.7.11.24)
MAP3K (EC 2.7.11.25)
Tau-protein kinase (EC 2.7.11.26)
(acetyl-CoA carboxylase) kinase (EC 2.7.11.27)
  • -
Tropomyosin kinase (EC 2.7.11.28)
  • -
Low-density-lipoprotein receptor kinase (EC 2.7.11.29)
  • -
Receptor protein serine/threonine kinase (EC 2.7.11.30)
MAP2K
Activity
Regulation
Classification
Kinetics
Types
Forms
Targets
sGC
NO donors
(prodrugs)
Enzyme
(inhibitors)
NOS
nNOS
iNOS
eNOS
Unsorted
Arginase
CAMK
Others
Portal:
Retrieved from "https://en.wikipedia.org/w/index.php?title=CGMP-dependent_protein_kinase&oldid=1150932157"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp